The aforementioned IFN-RCAN1 mediated inhibition of calcineurin signaling and adverse calcineurin-kynurenine interactions may play a role in the hypertrophic cardiomyopathy and hepatic fibrosis observed in DS/T21 persons. The gene discussed is RCAN1; the disease is Dravet syndrome.